US Stock Market Move | Lilly (LLY.US) rose by 3.8%, with major Wall Street firms maintaining their "buy" rating.
As of the press deadline, the stock rose by 3.8% to $649.66.
On Monday, the stock price of Eli Lilly (LLY.US) rose, as of the time of writing, the stock was up 3.8% at $649.66. On the news front, Deutsche Bank Aktiengesellschaft analyst James Shin maintained a "buy" rating on Eli Lilly, but lowered the target price to $900. Analysts from Furry Group, Morgan Stanley, J.P. Morgan, Citigroup, and Truist Financial also maintained a "buy" rating on the stock.
Related Articles
US Stock Market Move | Advent invests $2.5 billion to privatize Sapiens International (SPNS.US), which soars over 44%
US Stock Market Move | Q2 revenue falls short of expectations, CAVA Group (CAVA.US) plunges more than 16%
US Stock Market Move | Niu Technologies Sponsored ADR Class A(NIU.US) rose over 10% in the second quarter compared to the same period last year, turning a loss into a profit.
US Stock Market Move | Advent invests $2.5 billion to privatize Sapiens International (SPNS.US), which soars over 44%
US Stock Market Move | Q2 revenue falls short of expectations, CAVA Group (CAVA.US) plunges more than 16%
US Stock Market Move | Niu Technologies Sponsored ADR Class A(NIU.US) rose over 10% in the second quarter compared to the same period last year, turning a loss into a profit.
RECOMMEND
Hong Kong Stock Concepts | Boosting Consumption: Dual Interest Subsidy Programs Implemented to Benefit Key Sectors
13/08/2025
Countdown to Evergrande’s Delisting: HK$350 Billion in Liabilities, Only HK$2 Billion Recovered
13/08/2025
U.S. July Tariff Receipts Reach Record High, Yet Budget Deficit Continues to Grow
13/08/2025
